Published online
doi:10.1084/jem.20081736
The Journal of Experimental Medicine, Vol. 205, No. 10, 2187-2190
The Rockefeller University Press, 0022-1007 $30.00
© Yoshimura et al.
Chemerin reveals its chimeric nature
Teizo Yoshimura and
Joost J. Oppenheim
T.Y. and J.J.O. are at Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702
CORRESPONDENCE T.Y.: yoshimut{at}mail.nih.gov
ABSTRACT
Chemerin is a proinflammatory plasma protein that binds to the GPCR ChemR23/CMKLR1 on macrophages and plasmacytoid dendritic cells, and promotes chemotaxis. An orphan GPCR, CCRL2, has now been identified as an additional receptor for chemerin, providing a unique mechanism by which chemerin enhances inflammation. Furthermore, because recent data shows that chemerin-derived peptides possess antiinflammatory properties, chemerin may be involved in both the initiation and resolution of inflammation.
© 2008 Yoshimura and Oppenheim This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
Related Article
-
Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis
- Brian A. Zabel, Susumu Nakae, Luis Zúñiga, Ji-Yun Kim, Takao Ohyama, Carsten Alt, Junliang Pan, Hajime Suto, Dulce Soler, Samantha J. Allen, Tracy M. Handel, Chang Ho Song, Stephen J. Galli, and Eugene C. Butcher
J. Exp. Med. 2008 205: 2207-2220.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Lehrke, M., Becker, A., Greif, M., Stark, R., Laubender, R. P, von Ziegler, F., Lebherz, C., Tittus, J., Reiser, M., Becker, C., Goke, B., Leber, A. W, Parhofer, K. G, Broedl, U. C
(2009). Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol
161: 339-344
[Abstract]
[Full Text]